Pediatrics:塑料包装易致儿童血压高

2013-06-14 伊文 人民网

  据英国《每日邮报》5月22日最新报道,美国《儿科》杂志刊登的一项新研究发现,包括食品塑料包装在内的普通塑料中的化学物质会增加儿童患高血压的风险。   纽约大学朗格尼医学中心、华盛顿大学和宾夕法尼亚州立大学医学院的科学家对近3000名儿童,展开了一项大规模联合研究。结果发现,食品包装中的邻苯二甲酸酯(DEHP)等化学物质会导致儿童发育初期的重要代谢及激素异常。令科学家担忧的是,塑料地板、塑料杯

  据英国《每日邮报》5月22日最新报道,美国《儿科》杂志刊登的一项新研究发现,包括食品塑料包装在内的普通塑料中的化学物质会增加儿童患高血压的风险。

  纽约大学朗格尼医学中心、华盛顿大学和宾夕法尼亚州立大学医学院的科学家对近3000名儿童,展开了一项大规模联合研究。结果发现,食品包装中的邻苯二甲酸酯(DEHP)等化学物质会导致儿童发育初期的重要代谢及激素异常。令科学家担忧的是,塑料地板、塑料杯、沙滩球、塑料包装等物品中所含的无色无味有毒物质与青少年高血压发病率骤升有一定关系。

  新研究负责人,儿科、环境医学与人口健康教授利奥纳多·特拉桑德博士表示:早期研究发现,邻苯二甲酸酯会抑制心脏细胞功能,导致血管压力增加,危害血管健康。但是新研究首次揭示了邻苯二甲酸酯与儿童心脏健康之间的关联性。新研究表明,减少儿童接触有害环境化学物质,少吃塑料包装食品,对保护儿童心血管健康具有重要意义

Urinary Phthalates Are Associated with Higher Blood Pressure in Childhood
Objective
To examine associations of urinary phthalate levels with blood pressure (BP) and serum triglyceride and lipoprotein levels in children.
Study design
We performed a cross-sectional analysis of a subsample of US children aged 6-19 years who participated in the National Health and Nutrition Examination Survey between 2003 and 2008. We quantified exposure to 3 families of phthalates—low molecular weight, high molecular weight and di-2-ethylhexylphthalate (DEHP)—based on molar concentration of urinary metabolites. We assessed descriptive, bivariate, and multivariate associations with BP and lipid levels.
Results
Controlling for an array of sociodemographic and behavioral factors, as well as diet and body mass index, levels of metabolites of DEHP, a phthalate commonly found in processed foods, were associated with higher age-, sex-, and height-standardized BP. For each log unit (roughly 3-fold) increase in DEHP metabolites, a 0.041 SD unit increase in systolic BP z-score was identified (P = .047). Metabolites of low molecular weight phthalates commonly found in cosmetics and personal care products were not associated with BP. Phthalate metabolites were not associated with triglyceride levels, high-density lipoprotein level, or prehypertension.
Conclusions
Dietary phthalate exposure is associated with higher systolic BP in children and adolescents. Further work is needed to confirm these associations, as well as to evaluate opportunities for intervention.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=59215, encodeId=7c3b5921555, content=应注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Jan 25 16:58:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636696, encodeId=69031636696a6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Dec 28 04:26:00 CST 2013, time=2013-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725516, encodeId=86f61e25516af, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 01 12:26:00 CST 2014, time=2014-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958376, encodeId=9c6019583e6c8, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Oct 03 17:26:00 CST 2013, time=2013-10-03, status=1, ipAttribution=)]
    2016-01-25 忠诚向上

    应注意

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=59215, encodeId=7c3b5921555, content=应注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Jan 25 16:58:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636696, encodeId=69031636696a6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Dec 28 04:26:00 CST 2013, time=2013-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725516, encodeId=86f61e25516af, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 01 12:26:00 CST 2014, time=2014-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958376, encodeId=9c6019583e6c8, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Oct 03 17:26:00 CST 2013, time=2013-10-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=59215, encodeId=7c3b5921555, content=应注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Jan 25 16:58:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636696, encodeId=69031636696a6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Dec 28 04:26:00 CST 2013, time=2013-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725516, encodeId=86f61e25516af, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 01 12:26:00 CST 2014, time=2014-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958376, encodeId=9c6019583e6c8, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Oct 03 17:26:00 CST 2013, time=2013-10-03, status=1, ipAttribution=)]
    2014-01-01 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=59215, encodeId=7c3b5921555, content=应注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Jan 25 16:58:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636696, encodeId=69031636696a6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Dec 28 04:26:00 CST 2013, time=2013-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725516, encodeId=86f61e25516af, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 01 12:26:00 CST 2014, time=2014-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958376, encodeId=9c6019583e6c8, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Oct 03 17:26:00 CST 2013, time=2013-10-03, status=1, ipAttribution=)]
    2013-10-03 hbwxf

相关资讯

PAS2013:超重儿将早面临高血压风险

  华盛顿——在美国儿科学术团体(PAS)2013年会上,明尼苏达州布卢明顿HealthPartners教育研究所的Emily D. Parker博士报告称,在生长发育过程中出现超重或肥胖的儿童,早在3~5岁时就有可能罹患高血压。   这项研究分析了59,638名年龄介于3~17岁的儿童的体重和血压变化趋势。这些儿童数据来自加利福利亚洲、科罗拉多州和明尼苏达州的3个大型保险数据库2007~201

Hypertension:压力感受器刺激治疗对肾功能影响不大

颈动脉窦压力感受器刺激治疗(Baroreflex Activation Therapy,BAT)可有效的降低耐药性高血压患者的血压。而肾脏在长期血压调节中起着重要作用。长期BAT治疗对肾功能有何影响目前尚不清楚,荷兰的研究人员Alnima T等在Rheos Pivotal Trial研究的数据中分析长期治疗对肾功能的影响。 该共纳入322名患者。其中,组1中包含236例患者在压力感受器刺激装置植

Hypertension:老年高血压患者严格控制血压可增加脑血流量

研究证实老年人血压控制在150/90mmHg可减少卒中和心肌梗死风险,改善认知功能以及放缓或逆转脑血流量(CBF,cerebral blood flow )下降。有学者认为降压药物导致的低血压对老年人造成的危害大于高血压如低灌注导致晕厥、摔倒以及有可能加速萎缩和脑白质疏松。认知功能下降与CBF减少有关。预防CBF降低可减少老年高血压患者的认知障碍和情绪障碍。然而降压治疗对CBF的影响并不清楚。研究

PAS 2013:儿童高血压或影响其认知

  华盛顿——美国罗切斯特大学医学中心的小儿肾病专家Marc Lande医生在儿科学术学会(PAS)2013年会上报告了一项仍在进行中的研究的初步结果:患有高血压的儿童具有较差的注意力和语言、视觉记忆力。而且较低的社会经济地位似乎会放大这种效应,使高血压患儿的认知问题变得更严重。   他在接受采访时表示:“这些初步数据并未告诉我们为何会有这些差异,有可能是高血压本身导致的,因为我们知道大脑是高血

Hypertension:合并隐匿性高血压的糖尿病患者需进一步降压治疗

尽管大家对糖尿病患者隐匿性高血压(masked hypertension)的特点已经很清楚。然而对于这些患者临床上进行降压治疗的意义尚未完全清楚。IDACO研究(The current International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes )中的受试

JCEM:血压与中风风险之间呈U字形相关

在糖尿病患者中,控制血压(BP)可以降低中风的风险;然而,在糖尿病患者中间,最低的中风风险的是否伴随最低的血压水平仍不清除。在路易斯安那州立大学以医院为基础纵向研究的糖尿病患者中间,为了探讨不同血压水平与中风风险之间的种族特异性关系,来自美国路易斯安那州彭宁顿生物医学研究中心的Gang Hu教授及其团队进行了一项研究,该研究发现血压与中风风险之间呈U字形相关,在非裔美国人和白人2型糖尿病患者中间,